These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30318569)
21. Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (Deflux). Van Batavia JP; Nees SN; Fast AM; Combs AJ; Glassberg KI J Pediatr Urol; 2014 Jun; 10(3):482-7. PubMed ID: 24290224 [TBL] [Abstract][Full Text] [Related]
22. Ureteroneocystostomy after failed dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux treatment. Moreira-Pinto J; Osório A; Pereira J; Sousa C; de Castro JL; Réis A J Pediatr Urol; 2013 Oct; 9(5):665-9. PubMed ID: 22906586 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for obstructive complications after endoscopic correction of vesico-ureteral reflux using polyacrylate polyalcohol copolymer. Sizonov VV; Kagantsov IM; Mayr JM; Akramov NR; Pirogov AV; Gasanov ZA Medicine (Baltimore); 2020 May; 99(22):e20386. PubMed ID: 32481425 [TBL] [Abstract][Full Text] [Related]
24. Long-term incidence of febrile UTI after DxHA treatment of VUR. Fotso Kamdem A; Galli G; Aubert D J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062 [TBL] [Abstract][Full Text] [Related]
25. Comparison of dextranomer/hyaluronic acid based bulking agents in the treatment of vesicoureteral reflux in children: Deflux versus Vurdex. Pogorelić Z; Gudelj K; Budimir D; Todorić J; Jukić M; Furlan D; Košuljandić Đ; Saraga M Can J Urol; 2016 Jun; 23(3):8312-7. PubMed ID: 27347628 [TBL] [Abstract][Full Text] [Related]
26. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. Kirsch AJ; Perez-Brayfield MR; Scherz HC J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692 [TBL] [Abstract][Full Text] [Related]
27. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. Puri P; Mohanan N; Menezes M; Colhoun E J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016 [TBL] [Abstract][Full Text] [Related]
28. Late ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer. Şencan A; Yıldırım H; Özkan KU; Uçan B; Karkıner A; Hoşgör M Urology; 2014 Nov; 84(5):1188-93. PubMed ID: 25443932 [TBL] [Abstract][Full Text] [Related]
29. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results. Puri P; Chertin B; Velayudham M; Dass L; Colhoun E J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655 [TBL] [Abstract][Full Text] [Related]
31. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Oswald J; Riccabona M; Lusuardi L; Bartsch G; Radmayr C Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323 [TBL] [Abstract][Full Text] [Related]
32. Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience. Biočić M; Todorić J; Budimir D; Cvitković Roić A; Pogorelić Z; Jurić I; Šušnjar T Can J Surg; 2012 Oct; 55(5):301-6. PubMed ID: 22854114 [TBL] [Abstract][Full Text] [Related]
33. Endoscopic treatment of vesicoureteral reflux after kidney transplantation: outcomes and predictive factors of clinical and radiological success. Çilesiz NC; Onuk Ö; Özkan A; Kalkanlı A; Gezmiş CT; Nuhoğlu B Int Urol Nephrol; 2022 May; 54(5):1023-1029. PubMed ID: 35188622 [TBL] [Abstract][Full Text] [Related]
34. A comparison of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the endoscopic treatment of primary vesicoureteral reflux. Akin M; Erginel B; Karadag CA; Yildiz A; Ozçelik GS; Sever N; Genc NM; Dokucu AI Int Urol Nephrol; 2014 Nov; 46(11):2057-61. PubMed ID: 24966099 [TBL] [Abstract][Full Text] [Related]
35. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results. Friedmacher F; Colhoun E; Puri P J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405 [TBL] [Abstract][Full Text] [Related]
36. Open ureteroneocystostomy after failed endoscopic injection with three different bulking agents for the treatment of vesicoureteral reflux. Sencan A; Yıldırım H; Ozkan KU; Uçan B; Hoşgör M J Pediatr Surg; 2014 Nov; 49(11):1652-5. PubMed ID: 25475812 [TBL] [Abstract][Full Text] [Related]
37. Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary? García-Aparicio L; Blázquez-Gómez E; Vila Santandreu A; Camacho Diaz JA; Vila-Cots J; Ramos Cebrian M; de Haro I; Martin O; Tarrado X Actas Urol Esp; 2016 Dec; 40(10):635-639. PubMed ID: 27161091 [TBL] [Abstract][Full Text] [Related]
38. Clinical value of persistent but downgraded vesicoureteral reflux after dextranomer/hyaluronic acid injection in children. Baek M; Kang MY; Lee HE; Park K; Choi H J Korean Med Sci; 2013 Jul; 28(7):1060-4. PubMed ID: 23853490 [TBL] [Abstract][Full Text] [Related]
39. The use of polyacrylate-polyalcohol copolymer hydrogel in the endoscopic treatment of primary vesicoureteral reflux in children. Corbetta JP; Bortagaray JI; Weller S; Ruiz J; Burek C; Sager C; Durán V; Lopez JC J Pediatr Surg; 2015 Mar; 50(3):485-8. PubMed ID: 25746713 [TBL] [Abstract][Full Text] [Related]
40. Early results of endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer. Şencan A; Uçan B; Evciler H; Serdaroğlu E; Hoşgör M Urol Int; 2014; 92(2):219-22. PubMed ID: 24335079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]